Colombes, France

Nacera Hamdani

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Sanofi. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nacera Hamdani: Innovator in Cardiovascular Medicine

Introduction

Nacera Hamdani is a prominent inventor based in Colombes, France. She has made significant contributions to the field of cardiovascular medicine. Her innovative work focuses on the use of dronedarone, a medication that plays a crucial role in preventing cardiovascular hospitalization and mortality.

Latest Patents

Nacera Hamdani holds a patent for the "Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality." This patent outlines methods of using dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a medicament aimed at preventing cardiovascular issues. The patent also includes articles of manufacture and related packages.

Career Highlights

Nacera is currently employed at Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to focus on innovative solutions in the pharmaceutical industry. With her expertise, she has contributed to advancements in treatments for cardiovascular diseases.

Collaborations

Nacera collaborates with notable colleagues, including Davide Radzik and Martin Van Eickels. These partnerships enhance her research and development efforts, leading to impactful innovations in medicine.

Conclusion

Nacera Hamdani's contributions to cardiovascular medicine through her patent and work at Sanofi highlight her role as a key innovator in the field. Her dedication to improving patient outcomes is evident in her research and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…